Brief: Sunesis Pharmaceuticals Says Estimates That Cash, Cash Equivalents, Restricted Cash, Marketable Securities As Of Dec 31, 2019 Was About $34.6 Million

Viracta Therapeutics

03/03/2020 15:22

March 3 (Reuters) - Sunesis Pharmaceuticals Inc  SNSS.O :
    * SUNESIS PHARMACEUTICALS - ESTIMATES THAT CASH, CASH
EQUIVALENTS,
RESTRICTED CASH, MARKETABLE SECURITIES AS OF DEC 31, 2019 WAS
ABOUT $34.6 MILLION

Source text: (http://bit.ly/2TlAbgN)
Further company coverage:  SNSS.O 

 ((Reuters.Briefs@thomsonreuters.com;))